Actively Recruiting
Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis
Led by Papworth Hospital NHS Foundation Trust · Updated on 2025-12-17
50
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
Sponsors
P
Papworth Hospital NHS Foundation Trust
Lead Sponsor
L
LifeArc
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to learn about new sensors that measure changes in the body that happen during a chest infection, such as breathing rate and heart rate. This study will be with adults who have either cystic fibrosis or bronchiectasis who start treatment with intravenous antibiotics (usually for around 2 weeks). The main question it aims to answer is the change in sensor measure (such as heart rate) between the start and end of treatment for a chest infection. No follow up visits are required for this study.
CONDITIONS
Official Title
Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of cystic fibrosis based on genetic testing and/or sweat chloride levels, or CT-confirmed diagnosis of non-cystic fibrosis bronchiectasis
- Under the care of Royal Papworth Hospital
- Starting intravenous antibiotics for treatment of acute pulmonary exacerbation as defined by the Hill Criteria
You will not qualify if you...
- Unable to provide written informed consent
- Lung transplant recipients or on lung transplant waiting list
- Use of long-term oxygen therapy or non-invasive ventilation for respiratory failure
- Unwilling to consent to use of link anonymised home monitoring data for research
- Considered unsuitable for home monitoring by the investigator
- Admitted for elective antibiotic treatment, not for acute exacerbation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Royal Papworth Hospital NHS Foundation Trust
Cambridge, Cambridgeshire, United Kingdom, CB2 0AY
Actively Recruiting
Research Team
L
Lucy E Gale
CONTACT
V
Victoria Hughes, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here